Total Payments
$3,624
2024 Payments
$640.32
Companies
31
Transactions
145
Medicare Patients
1,756
Medicare Billing
$302,205
Payment Breakdown by Category
Food & Beverage$3,624 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,624 | 145 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $473.14 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $379.47 | 12 | $0 (2024) |
| Amgen Inc. | $349.35 | 35 | $0 (2024) |
| ABBVIE INC. | $249.99 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $212.82 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $210.59 | 6 | $0 (2024) |
| Boston Scientific Corporation | $187.71 | 2 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $162.94 | 5 | $0 (2023) |
| Medtronic, Inc. | $152.74 | 2 | $0 (2022) |
| Lilly USA, LLC | $128.77 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $640.32 | 25 | Gilead Sciences, Inc. ($173.04) |
| 2023 | $1,280 | 48 | Boston Scientific Corporation ($187.71) |
| 2022 | $850.90 | 41 | Bayer HealthCare Pharmaceuticals Inc. ($184.05) |
| 2021 | $852.88 | 31 | AbbVie Inc. ($144.04) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: VACCINE | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.18 | General |
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: HCV | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 07/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.70 | General |
| 04/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Bone Health | ||||||
| 03/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Cardio-renal | ||||||
| 03/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 03/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $82.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 01/19/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 01/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 434 | 4,284 | $329,420 | $92,726 |
| 2022 | 9 | 436 | 3,696 | $285,082 | $76,040 |
| 2021 | 13 | 513 | 4,053 | $291,193 | $86,137 |
| 2020 | 8 | 373 | 2,486 | $179,269 | $47,302 |
Total Patients
1,756
Total Services
14,519
Medicare Billing
$302,205
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 32 | 3,540 | $231,276 | $64,462 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 186 | $51,336 | $12,123 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $18,492 | $7,033 | 38.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 83 | $8,964 | $3,263 | 36.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 265 | $6,890 | $2,226 | 32.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,785 | $1,592 | 89.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 20 | $4,860 | $849.90 | 17.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $840.00 | $599.97 | 71.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 79 | $4,977 | $576.55 | 11.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 31 | 3,000 | $193,800 | $50,932 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 208 | $54,704 | $12,971 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $17,085 | $7,000 | 41.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 24 | 24 | $1,560 | $1,530 | 98.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 28 | $5,038 | $1,318 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 108 | 263 | $6,575 | $779.52 | 11.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $825.00 | $649.74 | 78.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 69 | $4,146 | $526.84 | 12.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 13 | 13 | $1,349 | $333.34 | 24.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 29 | 3,300 | $191,536 | $53,215 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 226 | $58,822 | $15,611 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 68 | 68 | $11,071 | $7,349 | 66.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 35 | 35 | $2,275 | $2,275 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 35 | $6,290 | $1,968 | 31.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $4,808 | $1,479 | 30.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $2,980 | $1,367 | 45.9% |
About Quinn Schulte, P.A
Quinn Schulte, P.A is a Physician Assistant healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982975652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Quinn Schulte, P.A has received a total of $3,624 in payments from pharmaceutical and medical device companies, with $640.32 received in 2024. These payments were reported across 145 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,624).
As a Medicare-enrolled provider, Schulte has provided services to 1,756 Medicare beneficiaries, totaling 14,519 services with total Medicare billing of $302,205. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Council Bluffs, IA
- Active Since 01/26/2012
- Last Updated 02/01/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1982975652
Products in Payments
- Kerendia (Drug) $379.47
- Epclusa (Drug) $211.94
- XARELTO (Drug) $210.59
- NUZYRA (Drug) $162.94
- UBRELVY (Drug) $158.19
- EVENITY (Biological) $156.14
- LEQVIO (Drug) $153.95
- Repatha (Biological) $145.26
- LINQ II (Device) $135.47
- NURTEC ODT (Drug) $128.79
- NUPLAZID (Drug) $103.35
- QUVIVIQ (Drug) $97.13
- QULIPTA (Drug) $91.80
- Yupelri (Drug) $88.27
- NEXLETOL (Drug) $85.42
- Rybelsus (Drug) $71.85
- MOUNJARO (Drug) $70.05
- ENTRESTO (Drug) $58.87
- TRULICITY (Drug) $58.72
- FARXIGA (Drug) $48.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Council Bluffs
Joyce Vacek, Pac, PAC
Physician Assistant — Payments: $6,942
Physician Assistant $6,942
Sara Rygol, Pa-C, PA-C
Physician Assistant — Payments: $6,705
Physician Assistant $6,705
Holly Baumann, Pa-C, PA-C
Physician Assistant — Payments: $4,026
Physician Assistant $4,026
Isabella Phillips, Pa, PA
Physician Assistant — Payments: $3,701
Physician Assistant $3,701
Mrs. Wendy Johnson, P.a.-C, P.A.-C
Physician Assistant — Payments: $3,592
Physician Assistant $3,592
Jared Scherer, Pa-C, PA-C
Physician Assistant — Payments: $2,071
Physician Assistant $2,071